Anti-GAD associated post-infectious cerebellitis after COVID-19 infection

The coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread rapidly all over the world. Besides severe pneumonia, it causes multisystemic disease, including neurological findings. Here, we present a patient with anti–...

Descripción completa

Detalles Bibliográficos
Autores principales: Emekli, Ahmed Serkan, Parlak, Asuman, Göcen, Nejla Yılmaz, Kürtüncü, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322110/
https://www.ncbi.nlm.nih.gov/pubmed/34328578
http://dx.doi.org/10.1007/s10072-021-05506-6
_version_ 1783730980769497088
author Emekli, Ahmed Serkan
Parlak, Asuman
Göcen, Nejla Yılmaz
Kürtüncü, Murat
author_facet Emekli, Ahmed Serkan
Parlak, Asuman
Göcen, Nejla Yılmaz
Kürtüncü, Murat
author_sort Emekli, Ahmed Serkan
collection PubMed
description The coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread rapidly all over the world. Besides severe pneumonia, it causes multisystemic disease, including neurological findings. Here, we present a patient with anti–glutamic acid decarboxylase (anti-GAD) antibody-associated cerebellitis developed after COVID-19 infection. The patient responded well to the immune treatments. Our knowledge about SARS-CoV-2 infection–related neurological disorders is limited. New data are needed to recognize the clinical spectrum of autoimmune neurological disorders that emerges after SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-8322110
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-83221102021-07-30 Anti-GAD associated post-infectious cerebellitis after COVID-19 infection Emekli, Ahmed Serkan Parlak, Asuman Göcen, Nejla Yılmaz Kürtüncü, Murat Neurol Sci Covid-19 The coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread rapidly all over the world. Besides severe pneumonia, it causes multisystemic disease, including neurological findings. Here, we present a patient with anti–glutamic acid decarboxylase (anti-GAD) antibody-associated cerebellitis developed after COVID-19 infection. The patient responded well to the immune treatments. Our knowledge about SARS-CoV-2 infection–related neurological disorders is limited. New data are needed to recognize the clinical spectrum of autoimmune neurological disorders that emerges after SARS-CoV-2 infection. Springer International Publishing 2021-07-30 2021 /pmc/articles/PMC8322110/ /pubmed/34328578 http://dx.doi.org/10.1007/s10072-021-05506-6 Text en © Fondazione Società Italiana di Neurologia 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Covid-19
Emekli, Ahmed Serkan
Parlak, Asuman
Göcen, Nejla Yılmaz
Kürtüncü, Murat
Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
title Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
title_full Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
title_fullStr Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
title_full_unstemmed Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
title_short Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
title_sort anti-gad associated post-infectious cerebellitis after covid-19 infection
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322110/
https://www.ncbi.nlm.nih.gov/pubmed/34328578
http://dx.doi.org/10.1007/s10072-021-05506-6
work_keys_str_mv AT emekliahmedserkan antigadassociatedpostinfectiouscerebellitisaftercovid19infection
AT parlakasuman antigadassociatedpostinfectiouscerebellitisaftercovid19infection
AT gocennejlayılmaz antigadassociatedpostinfectiouscerebellitisaftercovid19infection
AT kurtuncumurat antigadassociatedpostinfectiouscerebellitisaftercovid19infection

Ejemplares similares